280 related articles for article (PubMed ID: 28011481)
1. Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB.
Saengboonmee C; Seubwai W; Cha'on U; Sawanyawisuth K; Wongkham S; Wongkham C
Anticancer Res; 2017 Jan; 37(1):115-123. PubMed ID: 28011481
[TBL] [Abstract][Full Text] [Related]
2. Anoikis-resistant cholangiocarcinoma cells display aggressive characteristics and increase STAT3 activation.
Huyen NT; Prachayasittikul V; Chan-On W
J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):397-405. PubMed ID: 27107220
[TBL] [Abstract][Full Text] [Related]
3. Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway.
Wandee J; Prawan A; Senggunprai L; Kongpetch S; Tusskorn O; Kukongviriyapan V
Life Sci; 2018 Aug; 207():172-183. PubMed ID: 29847773
[TBL] [Abstract][Full Text] [Related]
4. Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma.
Chen H; Zhu B; Zhao L; Liu Y; Zhao F; Feng J; Jin Y; Sun J; Geng R; Wei Y
Cell Physiol Biochem; 2018; 47(2):641-653. PubMed ID: 29794468
[TBL] [Abstract][Full Text] [Related]
5. Capsaicin suppresses the migration of cholangiocarcinoma cells by down-regulating matrix metalloproteinase-9 expression via the AMPK-NF-κB signaling pathway.
Lee GR; Jang SH; Kim CJ; Kim AR; Yoon DJ; Park NH; Han IS
Clin Exp Metastasis; 2014 Dec; 31(8):897-907. PubMed ID: 25217963
[TBL] [Abstract][Full Text] [Related]
6. Mycoepoxydiene induces apoptosis and inhibits TPA-induced invasion in human cholangiocarcinoma cells via blocking NF-κB pathway.
Li W; Li M; Su X; Qin L; Miao M; Yu C; Shen Y; Luo Q; Chen Q
Biochimie; 2014 Jun; 101():183-91. PubMed ID: 24486723
[TBL] [Abstract][Full Text] [Related]
7. Diethyldithiocarbamate suppresses an NF-kappaB dependent metastatic pathway in cholangiocarcinoma cells.
Srikoon P; Kariya R; Kudo E; Goto H; Vaeteewoottacharn K; Taura M; Wongkham S; Okada S
Asian Pac J Cancer Prev; 2013; 14(7):4441-6. PubMed ID: 23992017
[TBL] [Abstract][Full Text] [Related]
8. Myricetin ameliorates cytokine-induced migration and invasion of cholangiocarcinoma cells via suppression of STAT3 pathway.
Tuponchai P; Kukongviriyapan V; Prawan A; Kongpetch S; Senggunprai L
J Cancer Res Ther; 2019; 15(1):157-163. PubMed ID: 30880773
[TBL] [Abstract][Full Text] [Related]
9. NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells.
Saengboonmee C; Phoomak C; Supabphol S; Covington KR; Hampton O; Wongkham C; Gibbs RA; Umezawa K; Seubwai W; Gingras MC; Wongkham S
Life Sci; 2020 Dec; 262():118548. PubMed ID: 33038372
[TBL] [Abstract][Full Text] [Related]
10. Cratoxylum formosum Extracts Inhibit Growth and Metastasis of Cholangiocarcinoma Cells by Modulating the NF-κB and STAT3 Pathways.
Senggunprai L; Thammaniwit W; Kukongviriyapan V; Prawan A; Kaewseejan N; Siriamornpun S
Nutr Cancer; 2016; 68(2):328-41. PubMed ID: 26908056
[TBL] [Abstract][Full Text] [Related]
11. Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways.
Prakobwong S; Gupta SC; Kim JH; Sung B; Pinlaor P; Hiraku Y; Wongkham S; Sripa B; Pinlaor S; Aggarwal BB
Carcinogenesis; 2011 Sep; 32(9):1372-80. PubMed ID: 21325634
[TBL] [Abstract][Full Text] [Related]
12. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
[TBL] [Abstract][Full Text] [Related]
13. Rhinacanthin-C Extracted from Rhinacanthus nasutus (L.) Inhibits Cholangiocarcinoma Cell Migration and Invasion by Decreasing MMP-2, uPA, FAK and MAPK Pathways.
Boueroy P; Saensa‑Ard S; Siripong P; Kanthawong S; Hahnvajanawong C
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3605-3613. PubMed ID: 30583689
[TBL] [Abstract][Full Text] [Related]
14. Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells.
Aneknan P; Kukongviriyapan V; Prawan A; Kongpetch S; Sripa B; Senggunprai L
Asian Pac J Cancer Prev; 2014; 15(12):5071-6. PubMed ID: 24998588
[TBL] [Abstract][Full Text] [Related]
15. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic activity and molecular targets of atractylodin in cholangiocarcinoma cells.
Mathema VB; Chaijaroenkul W; Na-Bangchang K
J Pharm Pharmacol; 2019 Feb; 71(2):185-195. PubMed ID: 30324612
[TBL] [Abstract][Full Text] [Related]
17. Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways.
Jaidee R; Kongpetch S; Senggunprai L; Prawan A; Kukongviriyapan U; Kukongviriyapan V
Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1681-1690. PubMed ID: 32383028
[TBL] [Abstract][Full Text] [Related]
18. FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling.
Lu Z; Wang J; Zheng T; Liang Y; Yin D; Song R; Pei T; Pan S; Jiang H; Liu L
BMC Cancer; 2014 Oct; 14():783. PubMed ID: 25344679
[TBL] [Abstract][Full Text] [Related]
19. Induction of phosphatase shatterproof 2 by evodiamine suppresses the proliferation and invasion of human cholangiocarcinoma.
Zhu B; Zhao L; Liu Y; Jin Y; Feng J; Zhao F; Sun J; Geng R; Wei Y
Int J Biochem Cell Biol; 2019 Mar; 108():98-110. PubMed ID: 30682488
[TBL] [Abstract][Full Text] [Related]
20. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
